Format
Sort by
Items per page

Send to

Choose Destination

Best matches for myasthenia gravis:

Myasthenia gravis: subgroup classification and therapeutic strategies. Gilhus NE et al. Lancet Neurol. (2015)

Myasthenia gravis: an update for the clinician. Sieb JP et al. Clin Exp Immunol. (2014)

Myasthenia gravis and the neuromuscular junction. Querol L et al. Curr Opin Neurol. (2013)

Search results

Items: 1 to 20 of 16967

1.

Functional Exercise Capacity Evaluated by Timed Walk Tests in Myasthenia Gravis.

Salcı Y, Karanfil E, Fil Balkan A, Çalık Kütükçü E, Ceren AN, Ayvat F, Bekircan-Kurt CE, Armutlu K.

Muscle Nerve. 2018 Sep 19. doi: 10.1002/mus.26345. [Epub ahead of print]

PMID:
30230561
2.

Marathons and myasthenia gravis: a case report.

Birnbaum S, Sharshar T, Eymard B, Theaudin M, Portero P, Hogrel JY.

BMC Neurol. 2018 Sep 18;18(1):145. doi: 10.1186/s12883-018-1150-0.

3.

Generalization after ocular onset in myasthenia gravis: a case series in Germany.

Li F, Hotter B, Swierzy M, Ismail M, Meisel A, Rückert JC.

J Neurol. 2018 Sep 17. doi: 10.1007/s00415-018-9056-8. [Epub ahead of print]

PMID:
30225725
4.

Brachial Plexus Neuritis Associated With Anti-Programmed Cell Death-1 Antibodies: Report of 2 Cases.

Alhammad RM, Dronca RS, Kottschade LA, Turner HJ, Staff NP, Mauermann ML, Tracy JA, Klein CJ.

Mayo Clin Proc Innov Qual Outcomes. 2017 Sep 1;1(2):192-197. doi: 10.1016/j.mayocpiqo.2017.07.004. eCollection 2017 Sep.

5.

Therapeutic potential of artesunate in experimental autoimmune myasthenia gravis by upregulated T regulatory cells and regulation of Th1/Th2 cytokines.

Meng QF, Zhang XX, Zhang Z, Chen W, Li XL, Wang YJ, Li FF, Li YB.

Pharmazie. 2018 Sep 1;73(9):526-532. doi: 10.1691/ph.2018.8516.

PMID:
30223936
6.

Disseminated extrapulmonary Legionella pneumophila infection presenting with panniculitis: case report and literature review.

Chitasombat MN, Ratchatanawin N, Visessiri Y.

BMC Infect Dis. 2018 Sep 17;18(1):467. doi: 10.1186/s12879-018-3378-0.

7.

Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome.

Walters M, Pittelkow MR, Hasserjian RP, Harris NL, Macon WR, Kurtin PJ, Rech KLG.

Am J Surg Pathol. 2018 Sep 15. doi: 10.1097/PAS.0000000000001158. [Epub ahead of print]

PMID:
30222603
8.

Myasthenia Gravis and Thymoma Surgery: A Clinical Update for the Cardiothoracic Anesthesiologist.

Cata JP, Lasala JD, Williams W, Mena GE.

J Cardiothorac Vasc Anesth. 2018 Jul 29. pii: S1053-0770(18)30574-3. doi: 10.1053/j.jvca.2018.07.036. [Epub ahead of print] Review.

PMID:
30219643
9.

Thymic epithelial neoplasms with Rhabdomyomatous component: a Clinicopathological and Immunohistochemical study of 7 cases.

Kalhor N, Moran CA.

Hum Pathol. 2018 Sep 11. pii: S0046-8177(18)30353-8. doi: 10.1016/j.humpath.2018.08.027. [Epub ahead of print]

PMID:
30217623
10.

Clinical & laboratory features of seventy-eight UK patients with Good's syndrome (thymoma & hypogammaglobulinemia).

Zaman M, Huissoon A, Buckland M, Patel S, Alachkar H, Edgar JD, Thomas M, Arumugakani G, Baxendale H, Burns S, Williams AP, Jolles S, Herriot R, Sargur RB, Arkwright PD.

Clin Exp Immunol. 2018 Sep 14. doi: 10.1111/cei.13216. [Epub ahead of print]

PMID:
30216434
11.

A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?

Filippelli E, Barone S, Granata A, Nisticò R, Valentino P.

Neurol Sci. 2018 Sep 13. doi: 10.1007/s10072-018-3554-4. [Epub ahead of print] No abstract available.

PMID:
30215155
12.

Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis.

Chen S, Xu MB, Zhou XL, Rong PQ, Jin TY, Zheng GQ.

Front Pharmacol. 2018 Aug 30;9:969. doi: 10.3389/fphar.2018.00969. eCollection 2018.

13.

What is the role of adipokines in myasthenia gravis?

Rozmilowska I, Czyzewski D, Mazur B, Adamczyk-Sowa M.

Ther Clin Risk Manag. 2018 Aug 28;14:1515-1525. doi: 10.2147/TCRM.S163966. eCollection 2018.

14.

Rituximab Treatment in Myasthaenia Gravis: Report of two paediatric cases.

Koul R, Al-Futaisi A, Abdelrahim R, Mani R, Abdwani R, Al-Asmi A.

Sultan Qaboos Univ Med J. 2018 May;18(2):e223-e227. doi: 10.18295/squmj.2018.18.02.018. Epub 2018 Sep 9.

15.

Myasthenia gravis unmasked by imatinib.

Kopp CR, Jandial A, Mishra K, Sandal R, Malhotra P.

Br J Haematol. 2018 Sep 10. doi: 10.1111/bjh.15557. [Epub ahead of print] No abstract available.

PMID:
30203413
16.

[Peripheral nervous system immunological disorder].

Erazo Torricelli R.

Medicina (B Aires). 2018;78 Suppl 2:82-87. Spanish.

17.

Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort.

Vanikieti K, Lowwongngam K, Padungkiatsagul T, Visudtibhan A, Poonyathalang A.

Pediatr Neurol. 2018 Jun 30. pii: S0887-8994(18)30136-X. doi: 10.1016/j.pediatrneurol.2018.06.007. [Epub ahead of print]

PMID:
30197221
18.

Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis.

Hocaoğlu M, Durmuş H, Özkan B, Yentür SP, Doğan Ö, Parman Y, Deymeer F, Saruhan-Direskeneli G.

J Neuroimmunol. 2018 Oct 15;323:36-42. doi: 10.1016/j.jneuroim.2018.07.006. Epub 2018 Jul 19.

PMID:
30196831
19.

Red Flags in the Assessment of Adult Ophthalmoplegia.

Merrill KS, Lee MS, McClelland CM.

J Binocul Vis Ocul Motil. 2018 Jan-Mar;68(1):20-23. doi: 10.1080/2576117X.2017.1420134. Epub 2018 Jan 17.

PMID:
30196782
20.

Microfluidic devices for disease modeling in muscle tissue.

Smoak MM, Pearce HA, Mikos AG.

Biomaterials. 2018 Aug 30. pii: S0142-9612(18)30619-7. doi: 10.1016/j.biomaterials.2018.08.059. [Epub ahead of print]

PMID:
30193908

Supplemental Content

Loading ...
Support Center